tradingkey.logo
搜尋

Mangoceuticals Inc

MGRX
添加自選
0.426USD
+0.014+3.45%
交易中 美東報價延遲15分鐘
5.91M總市值
虧損本益比TTM

關於 Mangoceuticals Inc 公司

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc簡介

公司代碼MGRX
公司名稱Mangoceuticals Inc
上市日期Mar 21, 2023
CEOCohen (Jacob D)
員工數量- -
證券類型Ordinary Share
年結日Mar 21
公司地址15110 Dallas Pkwy, Suite 600
城市DALLAS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編75248
電話18336264679
網址https://www.mangorx.com/
公司代碼MGRX
上市日期Mar 21, 2023
CEOCohen (Jacob D)

Mangoceuticals Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

常見問題

Mangoceuticals Inc的前五大股東是誰?

Mangoceuticals Inc的前五大股東如下:Dr. Kenny Myers

有多少機構持有Mangoceuticals Inc(MGRX)的股份?

截至2026Q1,共有37家機構持有Mangoceuticals Inc的股份,合計持有的股份價值約為2.67M,占公司總股份的15.75% 。與2025Q4相比,機構持股有所增加,增幅為2145026.00。
tradingkey.logo
* 參考、分析和交易策略由提供商Trading Central提供,觀點基於分析師的獨立評估和判斷,未考慮投資者的投資目標和財務狀況。
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有